KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 644 in its research report dated October 29, 2024.

As a significant milestone in India's pharma sector, the 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26 to 28, 2024 ...

James Fickel has dedicated $200 million he made betting on Ether to becoming one of the world’s biggest investors in those ...

from Sequence LifeScience, Inc. (“Sequence”). “Rebound adds to our portfolio of placental-derived advanced biomaterial products, sales of which through the first half of 2024 were in excess ...

At first, the experience is unnerving. I arrive at the Lifescience Building in Chuo City to find a metre-tall, gleaming white ...

Company advocates for commonsense reform in pivotal moment for U.S. cannabis industry –– One of the largest cannabis growers in the world, ...

Canadian Cannabis Net Sales Growth; 20% Fresh Produce Sales Growth; 111% International Medicinal Cannabis Sales GrowthCanadian Cannabis Remained #2 by Market Share and was Fastest Growing LP over Last ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

InProcess-LSP are a young organization, founded in 2014, they have since emerged as providers of groundbreaking process analytical technology for nanoparticle characterization. This article provides a ...

Supriya Lifescience Ltd share price was down by -1.77% from the previous closing price of ₹660.00. Who are peers of Supriya Lifescience Ltd? The peers of Supriya Lifescience Ltd are Sun ...

Pace platform delivers real-time aviation emissions analysis aimed at firms that finance the aviation sector and companies ...